Skip to main content
Emmessar Biotech & Nutrition Ltd. logo

Emmessar Biotech & Nutrition Ltd. — Investor Relations & Filings

Ticker · 524768 ISIN · INE634B01016 BSE.NS Manufacturing
Filings indexed 4 across all filing types
Latest filing 2026-05-14 Regulatory Filings
Country IN India
Listing BSE.NS 524768

About Emmessar Biotech & Nutrition Ltd.

https://www.ebnl.org

Emmessar Biotech & Nutrition Ltd. focuses on the research, development, and manufacturing of healthcare and wellness products. The company specializes in the integration of biotechnology with nutritional science to create specialized formulations. Its product portfolio primarily includes muscle care, skin care, and nutritional supplements designed for holistic health management. A key aspect of its operations is the "Veda-Ceuticals" approach, which combines traditional knowledge with modern scientific research to address chronic health conditions and promote overall well-being. The company provides solutions aimed at metabolic disorders, musculoskeletal health, and dermatological care. Its manufacturing processes emphasize quality control and the use of natural ingredients processed through advanced biotechnological methods to ensure efficacy and safety in its healthcare offerings.

Recent filings

Filing Released Lang Actions
Please refer attachment
Regulatory Filings Classification · 85% confidence The document is a stock‐exchange filing addressed to BSE, notifying the publication of a newspaper advertisement and compliance with SEBI circulars regarding physical share transfer re‐lodgement. It contains no financial statements, dividend, share issue, management changes, or meeting materials. It is a routine regulatory announcement that does not fit other specific categories, so it falls under the catch‐all Regulatory Filings (RNS).
2026-05-14 English
please refer attachment
Report Publication Announcement Classification · 85% confidence The document is a brief notice to the stock exchange under Regulation 30, enclosing newspaper advertisements of the company’s audited financial results for the quarter and fiscal year ended March 31, 2026. It does not contain the actual financial statements or substantive data itself but simply announces and provides evidence that the report has been published in newspapers. This aligns with the definition of a Report Publication Announcement (RPA) rather than an actual earnings release or a full financial report.
2026-05-13 English
please refer attachement
Audit Report / Information Classification · 82% confidence The document is a BSE filing titled “Outcome of Board Meeting” where the Board approves and encloses the Audited Standalone Financial Results for the year ended March 31, 2026, along with the Statutory Auditor’s Report (unmodified opinion) under SEBI LODR Regulation 33. It contains the Independent Auditor’s Report and the full audited financial results (including tables of revenues, expenses, profit, etc.) rather than a brief announcement. This is a standalone audit report and audited financial results summary – classifying as an Audit Report / Information (AR). FY 2026
2026-05-12 English
please refer attachment
Interim / Quarterly Report Classification · 82% confidence The document is a notice to the stock exchange of the outcome of a Board Meeting, containing the Board’s approval of the Audited Standalone Financial Results for the quarter and year ended 31 March 2026. It includes the full audited financial statements and the Independent Auditor’s Report with unmodified opinion. This is not a full Annual Report (no MD&A, no comprehensive annual disclosures), nor is it merely an announcement of publication. It contains substantive financial data for a quarterly (and year‐end) period rather than the entire annual report, matching the criteria for an Interim/Quarterly Report under Regulation 33 filings. Therefore, it should be classified as IR. FY 2026
2026-05-12 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.